Key Insights

Highlights

Success Rate

82% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 42/100

Termination Rate

9.1%

2 terminated out of 22 trials

Success Rate

81.8%

-4.8% vs benchmark

Late-Stage Pipeline

27%

6 trials in Phase 3/4

Results Transparency

11%

1 of 9 completed with results

Key Signals

1 with results82% success

Data Visualizations

Phase Distribution

18Total
Not Applicable (5)
Early P 1 (1)
P 2 (6)
P 3 (5)
P 4 (1)

Trial Status

Completed9
Unknown5
Recruiting4
Not Yet Recruiting2
Terminated2

Trial Success Rate

81.8%

Benchmark: 86.6%

Based on 9 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT07837713Phase 3Not Yet Recruiting

A Study of Chlorophyllin or Placebo With Standard Treatment for Late Radiation Induced Luminal Gastrointestinal Tract Bleeding

NCT06888817Phase 3Recruiting

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

NCT07552883Not ApplicableNot Yet Recruiting

Pseudomembrane Removal for Post-RT Nasopharyngeal Necrosis

NCT07231588Early Phase 1RecruitingPrimary

Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation

NCT06875583Not ApplicableRecruiting

The Radiation ProtEction for Dose RedUction in the Cardiac CathEter Lab Study: The REDUCE Trial

NCT06325982Not ApplicableRecruitingPrimary

Clinical Observation of Drug Retention Enema in Preventing Acute Radiation-induced Rectal Injury

NCT02972736CompletedPrimary

RadiatiOn Dose Among Different EndOvascular Procedures: the RODEO Study

NCT03660618Not ApplicableTerminated

LSFG-SKIN, Laser Speckle Flowgraphy

NCT05063773Not ApplicableUnknownPrimary

Novel Wireless Mixed Reality Headset for Image Guidance in Cardiac Catheterization Laboratory

NCT04059809Phase 2Completed

Photobiomodulation for Breast Cancer Radiodermatitis

NCT04818099Phase 3UnknownPrimary

Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing Radiotherapy

NCT03667859CompletedPrimary

Vaginal Elasticity Assessment Before and After Brachytherapy/Pelvic Radiation

NCT03907371Phase 2UnknownPrimary

The Effect of Donepezil in Radiotherapy-related Cognitive Impairment.

NCT03208413Phase 2UnknownPrimary

The Therapeutic Effect of Thalidomide in RI

NCT04152681Phase 2UnknownPrimary

Effect and Safety of Apatinib on Radiation-Induced Brain Injury

NCT03961217Completed

Return to Work Among Cancer Survivors With Treatment-induced Survivorship Syndromes

NCT02985164Phase 3Completed

Radiation Exposure During Endoscopic Retrograde Cholangiopancreatography

NCT00134628Phase 3TerminatedPrimary

Study to Determine if Hyperbaric Oxygen Therapy is Helpful for Treating Radiation Tissue Injuries

NCT02104271Phase 2CompletedPrimary

Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.

NCT00725244Phase 4CompletedPrimary

Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias

Scroll to load more

Research Network

Activity Timeline